Plain-English translation of NCT06275126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a website called CONSYDER that is designed to help young women with breast cancer make decisions about surgery. The website provides information and support to help you think through your options and feel more confident about the choice that's right for you. Researchers want to see if using CONSYDER reduces worry and confusion about surgical decisions, and whether it helps you communicate better with your doctors.
Young women facing breast cancer surgery often feel stressed and uncertain about their options. This study exists to see if a decision-support website can help reduce that confusion and anxiety, making it easier for you to choose the surgical path that matches your personal goals and values.
You likely qualify if…
You likely don't qualify if…
Some sites will start by using usual care without the website tool for 6 months, while others will immediately offer CONSYDER to all newly diagnosed young women as part of routine clinical care. If your site is offering CONSYDER, you'll have access to the website to explore your surgical options at your own pace. You may be asked to complete surveys about your decision-making experience, anxiety level, and confidence in talking with your doctors — either before and after using the tool, or at specific time points. The study will last approximately 30 months across four medical centers.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
United States